DNAメチル化修飾キット世界市場の見通し：詳細分析、予測(～2031年)

当レポートは、DNAメチル化修飾キット (DNA Methylation Modification Kit) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

• 概要 DNAメチル化修飾キット: 定義、特性、主要属性
• 市場セグメント：タイプ別
  • 世界のDNAメチル化修飾キット 市場規模：タイプ別, 2020 VS 2024 VS 2031
  • Bisulfite Conversion Method
  • Methylation-sensitive Restriction Enzyme Method
  • Immunological Method
  • Methylation Capture
• 市場セグメント：アプリケーション別
  • 世界のDNAメチル化修飾キット 市場規模：用途別, 2020 VS 2024 VS 2031
  • Disease Detection
  • Medical and Clinical Applications
  • Scientific Research
• 前提条件と制限
• 調査目的
• 対象期間

第2章 レポート概要

• 世界のDNAメチル化修飾キットの収益 推定および予測 2020-2031
• 世界のDNAメチル化修飾キット 収益：地域別
  • 収益比較: 2020 VS 2024 VS 2031
  • 収益実績と予測 地域別 (2020--2031)
  • 世界の収益市場シェア 地域別 (2020-2031)
• 世界のDNAメチル化修飾キット 売上予測・予想 2020-2031
• 世界のDNAメチル化修飾キット 販売：地域別
  • 売上比較: 2020 VS 2024 VS 2031
  • 販売実績と予測 地域別 (2020-2031)
  • 新興市場: 成長要因と投資動向
  • 世界の販売市場シェア 地域別 (2020-2031)

第3章 競合：企業別

• 世界のDNAメチル化修飾キット 販売：企業別
  • 世界の販売数量 ：企業別 (2020-2025)
  • 世界のトップ5とトップ10企業の市場シェア：販売数量別 (2024)
• 世界のDNAメチル化修飾キット 企業収益ランキングとTier
  • 世界の収益 (価格) ：企業別 (2020-2025)
  • 世界の主要企業収益ランキング (2023 vs. 2024)
  • 収益ベースのTierセグメンテーション (Tier 1, Tier 2, and Tier 3)
• 企業の収益性プロファイルと価格戦略
  • 総利益率 ：トップ企業別 (2020 VS 2024)
  • メーカー希望小売価格動向 (2020-2025)
• 主要企業 製造拠点、本社
• 主要製品タイプ 市場規模 ：企業別
  • Bisulfite Conversion Method Market Size by Manufacturers
  • Methylation-sensitive Restriction Enzyme Method Market Size by Manufacturers
  • Immunological Method Market Size by Manufacturers
  • Methylation Capture Market Size by Manufacturers
• 世界のDNAメチル化修飾キット 市場集中と力学
  • 世界の市場集中 (CR5 and HHI)
  • 新規参入／イグジットの影響分析
  • 戦略的な動き: 合併と買収、能力拡大、研究開発投資

第4章 世界の製品セグメンテーション分析

• 世界のDNAメチル化修飾キット 販売実績 タイプ別
  • 世界の販売実績と予測 タイプ別 (2020-2031)
  • 世界の販売市場シェア：タイプ別 (2020-2031)
• 世界のDNAメチル化修飾キット 収益動向 タイプ別
  • 世界の収益実績と予測 タイプ別 (2020-2031)
  • 世界の収益市場シェア：タイプ別 (2020-2031)
• 世界の平均 販売価格 (ASP) 動向 タイプ別 (2020-2031)
• 製品技術の差別化
• サブタイプの力学: 成長リーダー、収益性、リスク
  • 高成長な特定分野と採用ドライバー
  • 収益ホットスポットとコストドライバー
  • 代替品の脅威

第5章 世界の下流アプリケーション分析

• 世界のDNAメチル化修飾キット 販売：用途別
  • 世界の販売実績と予測 用途別 (2020-2031)
  • 世界の販売市場シェア：用途別 (2020-2031)
  • 高成長アプリケーション識別
  • 新興アプリケーションのケーススタディ
• 世界のDNAメチル化修飾キット 収益：用途別
  • 世界の実績al andの収益予測：用途別 (2020-2031)
  • の収益市場シェア：用途別 (2020-2031)
• 世界の価格力学 用途別 (2020-2031)
• 下流 顧客分析
  • トップ顧客 地域別
  • トップ顧客 用途別

第6章 北米

• 北米の販売数量と収益 (2020-2031)
• 北米の主要企業 売上 収益 2024年
• 北米のDNAメチル化修飾キット 売上高と収益：タイプ別 (2020-2031)
• 北米のDNAメチル化修飾キット 売上高と収益：アプリケーション別 (2020-2031)
• 北米の成長促進要因と市場障壁
• 北米のDNAメチル化修飾キット 市場規模：国別
  • 北米の収益：国別
  • 北米の販売動向 国別
  • US
  • カナダ
  • メキシコ

第7章 欧州

• 欧州の販売数量と収益 (2020-2031)
• 欧州の主要企業 売上 収益 2024年
• 欧州のDNAメチル化修飾キット 売上高と収益：タイプ別 (2020-2031)
• 欧州のDNAメチル化修飾キット 売上高と収益：アプリケーション別 (2020-2031)
• 欧州の成長促進要因と市場障壁
• 欧州のDNAメチル化修飾キット 市場規模：国別
  • 欧州の収益：国別
  • 欧州の販売動向 国別
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア

第8章 アジア太平洋地域

• アジア太平洋地域 販売数量と収益 (2020-2031)
• アジア太平洋地域 主要企業 売上 収益 2024年
• アジア太平洋地域 DNAメチル化修飾キット 売上高と収益：タイプ別 (2020-2031)
• アジア太平洋地域 DNAメチル化修飾キット 売上高と収益：アプリケーション別 (2020-2031)
• アジア太平洋地域 DNAメチル化修飾キット 市場規模：地域別
  • アジア太平洋地域 収益：地域別
  • アジア太平洋地域 販売動向 地域別
• アジア太平洋地域 成長促進要因と市場障壁
• 東南アジア
  • 東南アジアの収益：国別 (2020 VS 2024 VS 2031)
  • 主要国の分析: インドネシア, ベトナム, タイ, マレーシア, フィリピン
• 中国
• 日本
• 韓国
• 台湾
• インド

第9章 中南米

• 中南米 販売数量と収益 (2020-2031)
• 中南米 主要企業 売上 収益 2024年
• 中南米 DNAメチル化修飾キット 売上高と収益：タイプ別 (2020-2031)
• 中南米 DNAメチル化修飾キット 売上高と収益：アプリケーション別 (2020-2031)
• 中南米 投資機会と主な課題
• 中南米 DNAメチル化修飾キット 市場規模：国別
  • 中南米 収益動向：国別 (2020 VS 2024 VS 2031)
  • ブラジル
  • アルゼンチン

第10章 中東・アフリカ

• 中東・アフリカの販売数量と収益 (2020-2031)
• 中東・アフリカの主要企業 売上 収益 2024年
• 中東・アフリカのDNAメチル化修飾キット 売上高と収益：タイプ別 (2020-2031)
• 中東・アフリカのDNAメチル化修飾キット 売上高と収益：アプリケーション別 (2020-2031)
• 中東・アフリカの投資機会と主な課題
• 中東・アフリカのDNAメチル化修飾キット 市場規模：国別
  • 中東・アフリカの収益動向：国別 (2020 VS 2024 VS 2031)
  • 湾岸協力理事会諸国
  • トルコ
  • エジプト
  • 南アフリカ

第11章 企業プロファイル

• Solarbio
• Abcam
• Bersinbio
• diagbio
• New England Biolabs
• Thermo Fisher Scientific
• Proteintech Group, Inc
• Active Motif
• Vazyme
• A&A Biotechnology
• QIAGEN
• Creative Biogene
• EpiGenie
• BioChain
• Biosense

第12章 バリューチェーンとサプライチェーン分析

• DNAメチル化修飾キット 産業チェーン
• DNAメチル化修飾キット 上流材料分析
  • 原材料
  • 主要サプライヤー市場シェアとリスク評価
• DNAメチル化修飾キット 一貫生産分析
  • 製造拠点分析
  • 地域生産市場シェア (2020-2031)
  • 規制および貿易政策の生産への影響
  • 生産技術概要
  • 地域コストの促進要因
• DNAメチル化修飾キット 販売チャネルと流通ネットワーク
  • 販売チャネル
  • 卸業者

第13章 DNAメチル化修飾キット 市場動向

• 業界動向と進化
• 市場 成長ドライバーと新興の機会
• 市場の課題、リスク、抑制

第14章 主な調査結果 世界のDNAメチル化修飾キットの主な市場調査結果

第15章 付録

List of Tables

Table 1. Global DNA Methylation Modification Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global DNA Methylation Modification Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global DNA Methylation Modification Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global DNA Methylation Modification Kit Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global DNA Methylation Modification Kit Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global DNA Methylation Modification Kit Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global DNA Methylation Modification Kit Sales by Region (2020-2025) & (K Units)

Table 8. Global DNA Methylation Modification Kit Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global DNA Methylation Modification Kit Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global DNA Methylation Modification Kit Sales Share by Manufacturers (2020-2025)

Table 12. Global DNA Methylation Modification Kit Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global DNA Methylation Modification Kit Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers'Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global DNA Methylation Modification Kit by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Methylation Modification Kit as of 2024)

Table 16. Global DNA Methylation Modification Kit Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global DNA Methylation Modification Kit Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers DNA Methylation Modification Kit Manufacturing Base and Headquarters

Table 19. Global DNA Methylation Modification Kit Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) - Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global DNA Methylation Modification Kit Sales by Type (2020-2025) & (K Units)

Table 23. Global DNA Methylation Modification Kit Sales by Type (2026-2031) & (K Units)

Table 24. Global DNA Methylation Modification Kit Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global DNA Methylation Modification Kit Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global DNA Methylation Modification Kit ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global DNA Methylation Modification Kit Sales by Application (2020-2025) & (K Units)

Table 29. Global DNA Methylation Modification Kit Sales by Application (2026-2031) & (K Units)

Table 30. DNA Methylation Modification Kit High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global DNA Methylation Modification Kit Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global DNA Methylation Modification Kit Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global DNA Methylation Modification Kit ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America DNA Methylation Modification Kit Growth Accelerators and Market Barriers

Table 37. North America DNA Methylation Modification Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America DNA Methylation Modification Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe DNA Methylation Modification Kit Growth Accelerators and Market Barriers

Table 40. Europe DNA Methylation Modification Kit Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe DNA Methylation Modification Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific DNA Methylation Modification Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific DNA Methylation Modification Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific DNA Methylation Modification Kit Growth Accelerators and Market Barriers

Table 45. Southeast Asia DNA Methylation Modification Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America DNA Methylation Modification Kit Investment Opportunities and Key Challenges

Table 47. Central and South America DNA Methylation Modification Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa DNA Methylation Modification Kit Investment Opportunities and Key Challenges

Table 49. Middle East and Africa DNA Methylation Modification Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Solarbio Corporation Information

Table 51. Solarbio Description and Major Businesses

Table 52. Solarbio Product Models, Descriptions and Specifications

Table 53. Solarbio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Solarbio Sales Value Proportion by Product in 2024

Table 55. Solarbio Sales Value Proportion by Application in 2024

Table 56. Solarbio Sales Value Proportion by Geographic Area in 2024

Table 57. Solarbio DNA Methylation Modification Kit SWOT Analysis

Table 58. Solarbio Recent Developments

Table 59. Abcam Corporation Information

Table 60. Abcam Description and Major Businesses

Table 61. Abcam Product Models, Descriptions and Specifications

Table 62. Abcam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Abcam Sales Value Proportion by Product in 2024

Table 64. Abcam Sales Value Proportion by Application in 2024

Table 65. Abcam Sales Value Proportion by Geographic Area in 2024

Table 66. Abcam DNA Methylation Modification Kit SWOT Analysis

Table 67. Abcam Recent Developments

Table 68. Bersinbio Corporation Information

Table 69. Bersinbio Description and Major Businesses

Table 70. Bersinbio Product Models, Descriptions and Specifications

Table 71. Bersinbio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Bersinbio Sales Value Proportion by Product in 2024

Table 73. Bersinbio Sales Value Proportion by Application in 2024

Table 74. Bersinbio Sales Value Proportion by Geographic Area in 2024

Table 75. Bersinbio DNA Methylation Modification Kit SWOT Analysis

Table 76. Bersinbio Recent Developments

Table 77. diagbio Corporation Information

Table 78. diagbio Description and Major Businesses

Table 79. diagbio Product Models, Descriptions and Specifications

Table 80. diagbio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. diagbio Sales Value Proportion by Product in 2024

Table 82. diagbio Sales Value Proportion by Application in 2024

Table 83. diagbio Sales Value Proportion by Geographic Area in 2024

Table 84. diagbio DNA Methylation Modification Kit SWOT Analysis

Table 85. diagbio Recent Developments

Table 86. New England Biolabs Corporation Information

Table 87. New England Biolabs Description and Major Businesses

Table 88. New England Biolabs Product Models, Descriptions and Specifications

Table 89. New England Biolabs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. New England Biolabs Sales Value Proportion by Product in 2024

Table 91. New England Biolabs Sales Value Proportion by Application in 2024

Table 92. New England Biolabs Sales Value Proportion by Geographic Area in 2024

Table 93. New England Biolabs DNA Methylation Modification Kit SWOT Analysis

Table 94. New England Biolabs Recent Developments

Table 95. Thermo Fisher Scientific Corporation Information

Table 96. Thermo Fisher Scientific Description and Major Businesses

Table 97. Thermo Fisher Scientific Product Models, Descriptions and Specifications

Table 98. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Thermo Fisher Scientific Recent Developments

Table 100. Proteintech Group, Inc Corporation Information

Table 101. Proteintech Group, Inc Description and Major Businesses

Table 102. Proteintech Group, Inc Product Models, Descriptions and Specifications

Table 103. Proteintech Group, Inc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Proteintech Group, Inc Recent Developments

Table 105. Active Motif Corporation Information

Table 106. Active Motif Description and Major Businesses

Table 107. Active Motif Product Models, Descriptions and Specifications

Table 108. Active Motif Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Active Motif Recent Developments

Table 110. Vazyme Corporation Information

Table 111. Vazyme Description and Major Businesses

Table 112. Vazyme Product Models, Descriptions and Specifications

Table 113. Vazyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Vazyme Recent Developments

Table 115. A&A Biotechnology Corporation Information

Table 116. A&A Biotechnology Description and Major Businesses

Table 117. A&A Biotechnology Product Models, Descriptions and Specifications

Table 118. A&A Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. A&A Biotechnology Recent Developments

Table 120. QIAGEN Corporation Information

Table 121. QIAGEN Description and Major Businesses

Table 122. QIAGEN Product Models, Descriptions and Specifications

Table 123. QIAGEN Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. QIAGEN Recent Developments

Table 125. Creative Biogene Corporation Information

Table 126. Creative Biogene Description and Major Businesses

Table 127. Creative Biogene Product Models, Descriptions and Specifications

Table 128. Creative Biogene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. Creative Biogene Recent Developments

Table 130. EpiGenie Corporation Information

Table 131. EpiGenie Description and Major Businesses

Table 132. EpiGenie Product Models, Descriptions and Specifications

Table 133. EpiGenie Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. EpiGenie Recent Developments

Table 135. BioChain Corporation Information

Table 136. BioChain Description and Major Businesses

Table 137. BioChain Product Models, Descriptions and Specifications

Table 138. BioChain Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 139. BioChain Recent Developments

Table 140. Biosense Corporation Information

Table 141. Biosense Description and Major Businesses

Table 142. Biosense Product Models, Descriptions and Specifications

Table 143. Biosense Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 144. Biosense Recent Developments

Table 145. Key Raw Materials Distribution

Table 146. Raw Materials Key Suppliers

Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 148. Milestones in Production Technology Evolution

Table 149. Distributors List

Table 150. Market Trends and Market Evolution

Table 151. Market Drivers and Opportunities

Table 152. Market Challenges, Risks, and Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. DNA Methylation Modification Kit Product Picture

Figure 2. Global DNA Methylation Modification Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Bisulfite Conversion Method Product Picture

Figure 4. Methylation-sensitive Restriction Enzyme Method Product Picture

Figure 5. Immunological Method Product Picture

Figure 6. Methylation Capture Product Picture

Figure 7. Global DNA Methylation Modification Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Disease Detection

Figure 9. Medical and Clinical Applications

Figure 10. Scientific Research

Figure 11. DNA Methylation Modification Kit Report Years Considered

Figure 12. Global DNA Methylation Modification Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 14. Global DNA Methylation Modification Kit Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 15. Global DNA Methylation Modification Kit Revenue Market Share by Region (2020-2031)

Figure 16. Global DNA Methylation Modification Kit Sales (2020-2031) & (K Units)

Figure 17. Global DNA Methylation Modification Kit Sales (CAGR) by Region (2020-2031) (K Units)

Figure 18. Global DNA Methylation Modification Kit Sales Market Share by Region (2020-2031)

Figure 19. Top 5 and Top 10 Manufacturers DNA Methylation Modification Kit Sales Volume Market Share in 2024

Figure 20. Global DNA Methylation Modification Kit Revenue Market Share Ranking (2024)

Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 22. Bisulfite Conversion Method Revenue Market Share by Manufacturer in 2024

Figure 23. Methylation-sensitive Restriction Enzyme Method Revenue Market Share by Manufacturer in 2024

Figure 24. Immunological Method Revenue Market Share by Manufacturer in 2024

Figure 25. Methylation Capture Revenue Market Share by Manufacturer in 2024

Figure 26. Global DNA Methylation Modification Kit Sales Market Share by Type (2020-2031)

Figure 27. Global DNA Methylation Modification Kit Revenue Market Share by Type (2020-2031)

Figure 28. Global DNA Methylation Modification Kit Sales Market Share by Application (2020-2031)

Figure 29. Global DNA Methylation Modification Kit Revenue Market Share by Application (2020-2031)

Figure 30. North America DNA Methylation Modification Kit Sales YoY (2020-2031) & (K Units)

Figure 31. North America DNA Methylation Modification Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 32. North America Top 5 Manufacturers DNA Methylation Modification Kit Sales Revenue (US$ Million) in 2024

Figure 33. North America DNA Methylation Modification Kit Sales Volume (K Units) by Type (2020- 2031)

Figure 34. North America DNA Methylation Modification Kit Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 35. North America DNA Methylation Modification Kit Sales Volume (K Units) by Application (2020-2031)

Figure 36. North America DNA Methylation Modification Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 37. US DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 38. Canada DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 39. Mexico DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 40. Europe DNA Methylation Modification Kit Sales YoY (2020-2031) & (K Units)

Figure 41. Europe DNA Methylation Modification Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 42. Europe Top 5 Manufacturers DNA Methylation Modification Kit Sales Revenue (US$ Million) in 2024

Figure 43. Europe DNA Methylation Modification Kit Sales Volume (K Units) by Type (2020-2031)

Figure 44. Europe DNA Methylation Modification Kit Sales Revenue (US$ Million) by Type (2020-2031)

Figure 45. Europe DNA Methylation Modification Kit Sales Volume (K Units) by Application (2020-2031)

Figure 46. Europe DNA Methylation Modification Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 47. Germany DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 48. France DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 49. U.K. DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 50. Italy DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 51. Russia DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 52. Asia-Pacific DNA Methylation Modification Kit Sales YoY (2020-2031) & (K Units)

Figure 53. Asia-Pacific DNA Methylation Modification Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 54. Asia-Pacific Top 8 Manufacturers DNA Methylation Modification Kit Sales Revenue (US$ Million) in 2024

Figure 55. Asia-Pacific DNA Methylation Modification Kit Sales Volume (K Units) by Type (2020- 2031)

Figure 56. Asia-Pacific DNA Methylation Modification Kit Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 57. Asia-Pacific DNA Methylation Modification Kit Sales Volume (K Units) by Application (2020-2031)

Figure 58. Asia-Pacific DNA Methylation Modification Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 59. Indonesia DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 60. Japan DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 61. South Korea DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 62. China Taiwan DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 63. India DNA Methylation Modification Kit Revenue (2020-2031) & (US$ Million)

Figure 64. Central and South America DNA Methylation Modification Kit Sales YoY (2020-2031) & (K Units)

Figure 65. Central and South America DNA Methylation Modification Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 66. Central and South America Top 5 Manufacturers DNA Methylation Modification Kit Sales Revenue (US$ Million) in 2024

Figure 67. Central and South America DNA Methylation Modification Kit Sales Volume (K Units) by Type (2021-2031)

Figure 68. Central and South America DNA Methylation Modification Kit Sales Revenue (US$ Million) by Type (2020-2031)

Figure 69. Central and South America DNA Methylation Modification Kit Sales Volume (K Units) by Application (2020-2031)

Figure 70. Central and South America DNA Methylation Modification Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 71. Brazil DNA Methylation Modification Kit Revenue (2020-2025) & (US$ Million)

Figure 72. Argentina DNA Methylation Modification Kit Revenue (2020-2025) & (US$ Million)

Figure 73. Middle East, and Africa DNA Methylation Modification Kit Sales YoY (2020-2031) & (K Units)

Figure 74. Middle East and Africa DNA Methylation Modification Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 75. Middle East and Africa Top 5 Manufacturers DNA Methylation Modification Kit Sales Revenue (US$ Million) in 2024

Figure 76. Middle East and Africa DNA Methylation Modification Kit Sales Volume (K Units) by Type (2021-2031)

Figure 77. South America DNA Methylation Modification Kit Sales Revenue (US$ Million) by Type (2020-2031)

Figure 78. Middle East and Africa DNA Methylation Modification Kit Sales Volume (K Units) by Application (2020-2031)

Figure 79. Middle East and Africa DNA Methylation Modification Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 80. GCC Countries DNA Methylation Modification Kit Revenue (2020-2025) & (US$ Million)

Figure 81. Turkey DNA Methylation Modification Kit Revenue (2020-2025) & (US$ Million)

Figure 82. Egypt DNA Methylation Modification Kit Revenue (2020-2025) & (US$ Million)

Figure 83. South Africa DNA Methylation Modification Kit Revenue (2020-2025) & (US$ Million)

Figure 84. DNA Methylation Modification Kit Industry Chain Mapping

Figure 85. Regional DNA Methylation Modification Kit Manufacturing Base Distribution (%)

Figure 86. Global DNA Methylation Modification Kit Production Market Share by Region (2020-2031)

Figure 87. DNA Methylation Modification Kit Production Process

Figure 88. Regional DNA Methylation Modification Kit Production Cost Structure

Figure 89. Channels of Distribution (Direct Vs Distribution)

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

This research report focuses on the DNA Methylation Modification Kit Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Introduction to DNA Methylation Modification Kit: Definition, Properties, and Key Attributes
• 1.2 Market Segmentation by Type
  • 1.2.1 Global DNA Methylation Modification Kit Market Size by Type, 2020 VS 2024 VS 2031
  • 1.2.2 Bisulfite Conversion Method
  • 1.2.3 Methylation-sensitive Restriction Enzyme Method
  • 1.2.4 Immunological Method
  • 1.2.5 Methylation Capture
• 1.3 Market Segmentation by Application
  • 1.3.1 Global DNA Methylation Modification Kit Market Size by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Disease Detection
  • 1.3.3 Medical and Clinical Applications
  • 1.3.4 Scientific Research
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global DNA Methylation Modification Kit Revenue Estimates and Forecasts 2020-2031
• 2.2 Global DNA Methylation Modification Kit Revenue by Region
  • 2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
  • 2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
  • 2.2.3 Global Revenue Market Share by Region (2020-2031)
• 2.3 Global DNA Methylation Modification Kit Sales Estimates and Forecasts 2020-2031
• 2.4 Global DNA Methylation Modification Kit Sales by Region
  • 2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
  • 2.4.2 Historical and Forecasted Sales by Region (2020-2031)
  • 2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
  • 2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

• 3.1 Global DNA Methylation Modification Kit Sales by Manufacturers
  • 3.1.1 Global Sales Volume by Manufacturers (2020-2025)
  • 3.1.2 Global Top 5 and Top 10 Manufacturers'Market Share by Sales Volume (2024)
• 3.2 Global DNA Methylation Modification Kit Manufacturer Revenue Rankings and Tiers
  • 3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
  • 3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
  • 3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
• 3.3 Manufacturer Profitability Profiles and Pricing Strategies
  • 3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
  • 3.3.2 Manufacturer-Level Price Trends (2020-2025)
• 3.4 Key Manufacturers Manufacturing Base and Headquarters
• 3.5 Main Product Type Market Size by Manufacturers
  • 3.5.1 Bisulfite Conversion Method Market Size by Manufacturers
  • 3.5.2 Methylation-sensitive Restriction Enzyme Method Market Size by Manufacturers
  • 3.5.3 Immunological Method Market Size by Manufacturers
  • 3.5.4 Methylation Capture Market Size by Manufacturers
• 3.6 Global DNA Methylation Modification Kit Market Concentration and Dynamics
  • 3.6.1 Global Market Concentration (CR5 and HHI)
  • 3.6.2 Entrant/Exit Impact Analysis
  • 3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

• 4.1 Global DNA Methylation Modification Kit Sales Performance by Type
  • 4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
  • 4.1.2 Global Sales Market Share by Type (2020-2031)
• 4.2 Global DNA Methylation Modification Kit Revenue Trends by Type
  • 4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
  • 4.2.2 Global Revenue Market Share by Type (2020-2031)
• 4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
• 4.4 Product Technology Differentiation
• 4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
  • 4.5.1 High-Growth Niches and Adoption Drivers
  • 4.5.2 Profitability Hotspots and Cost Drivers
  • 4.5.3 Substitution Threats

5 Global Downstream Application Analysis

• 5.1 Global DNA Methylation Modification Kit Sales by Application
  • 5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
  • 5.1.2 Global Sales Market Share by Application (2020-2031)
  • 5.1.3 High-Growth Application Identification
  • 5.1.4 Emerging Application Case Studies
• 5.2 Global DNA Methylation Modification Kit Revenue by Application
  • 5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
  • 5.2.2 Revenue Market Share by Application (2020-2031)
• 5.3 Global Pricing Dynamics by Application (2020-2031)
• 5.4 Downstream Customer Analysis
  • 5.4.1 Top Customers by Region
  • 5.4.2 Top Customers by Application

6 North America

• 6.1 North America Sales Volume and Revenue (2020-2031)
• 6.2 North America Key Manufacturers Sales Revenue in 2024
• 6.3 North America DNA Methylation Modification Kit Sales and Revenue by Type (2020-2031)
• 6.4 North America DNA Methylation Modification Kit Sales and Revenue by Application (2020-2031)
• 6.5 North America Growth Accelerators and Market Barriers
• 6.6 North America DNA Methylation Modification Kit Market Size by Country
  • 6.6.1 North America Revenue by Country
  • 6.6.2 North America Sales Trends by Country
  • 6.6.3 US
  • 6.6.4 Canada
  • 6.6.5 Mexico

7 Europe

• 7.1 Europe Sales Volume and Revenue (2020-2031)
• 7.2 Europe Key Manufacturers Sales Revenue in 2024
• 7.3 Europe DNA Methylation Modification Kit Sales and Revenue by Type (2020-2031)
• 7.4 Europe DNA Methylation Modification Kit Sales and Revenue by Application (2020-2031)
• 7.5 Europe Growth Accelerators and Market Barriers
• 7.6 Europe DNA Methylation Modification Kit Market Size by Country
  • 7.6.1 Europe Revenue by Country
  • 7.6.2 Europe Sales Trends by Country
  • 7.6.3 Germany
  • 7.6.4 France
  • 7.6.5 U.K.
  • 7.6.6 Italy
  • 7.6.7 Russia

8 Asia-Pacific

• 8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
• 8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
• 8.3 Asia-Pacific DNA Methylation Modification Kit Sales and Revenue by Type (2020-2031)
• 8.4 Asia-Pacific DNA Methylation Modification Kit Sales and Revenue by Application (2020-2031)
• 8.5 Asia-Pacific DNA Methylation Modification Kit Market Size by Region
  • 8.5.1 Asia-Pacific Revenue by Region
  • 8.5.2 Asia-Pacific Sales Trends by Region
• 8.6 Asia-Pacific Growth Accelerators and Market Barriers
• 8.7 Southeast Asia
  • 8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
  • 8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
• 8.8 China
• 8.9 Japan
• 8.10 South Korea
• 8.11 China Taiwan
• 8.12 India

9 Central and South America

• 9.1 Central and South America Sales Volume and Revenue (2020-2031)
• 9.2 Central and South America Key Manufacturers Sales Revenue in 2024
• 9.3 Central and South America DNA Methylation Modification Kit Sales and Revenue by Type (2020-2031)
• 9.4 Central and South America DNA Methylation Modification Kit Sales and Revenue by Application (2020-2031)
• 9.5 Central and South America Investment Opportunities and Key Challenges
• 9.6 Central and South America DNA Methylation Modification Kit Market Size by Country
  • 9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
  • 9.6.2 Brazil
  • 9.6.3 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
• 10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
• 10.3 Middle East and Africa DNA Methylation Modification Kit Sales and Revenue by Type (2020-2031)
• 10.4 Middle East and Africa DNA Methylation Modification Kit Sales and Revenue by Application (2020-2031)
• 10.5 Middle East and Africa Investment Opportunities and Key Challenges
• 10.6 Middle East and Africa DNA Methylation Modification Kit Market Size by Country
  • 10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
  • 10.6.2 GCC Countries
  • 10.6.3 Turkey
  • 10.6.4 Egypt
  • 10.6.5 South Africa

11 Corporate Profile

• 11.1 Solarbio
  • 11.1.1 Solarbio Corporation Information
  • 11.1.2 Solarbio Business Overview
  • 11.1.3 Solarbio DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.1.4 Solarbio DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.1.5 Solarbio DNA Methylation Modification Kit Sales by Product in 2024
  • 11.1.6 Solarbio DNA Methylation Modification Kit Sales by Application in 2024
  • 11.1.7 Solarbio DNA Methylation Modification Kit Sales by Geographic Area in 2024
  • 11.1.8 Solarbio DNA Methylation Modification Kit SWOT Analysis
  • 11.1.9 Solarbio Recent Developments
• 11.2 Abcam
  • 11.2.1 Abcam Corporation Information
  • 11.2.2 Abcam Business Overview
  • 11.2.3 Abcam DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.2.4 Abcam DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.2.5 Abcam DNA Methylation Modification Kit Sales by Product in 2024
  • 11.2.6 Abcam DNA Methylation Modification Kit Sales by Application in 2024
  • 11.2.7 Abcam DNA Methylation Modification Kit Sales by Geographic Area in 2024
  • 11.2.8 Abcam DNA Methylation Modification Kit SWOT Analysis
  • 11.2.9 Abcam Recent Developments
• 11.3 Bersinbio
  • 11.3.1 Bersinbio Corporation Information
  • 11.3.2 Bersinbio Business Overview
  • 11.3.3 Bersinbio DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.3.4 Bersinbio DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.3.5 Bersinbio DNA Methylation Modification Kit Sales by Product in 2024
  • 11.3.6 Bersinbio DNA Methylation Modification Kit Sales by Application in 2024
  • 11.3.7 Bersinbio DNA Methylation Modification Kit Sales by Geographic Area in 2024
  • 11.3.8 Bersinbio DNA Methylation Modification Kit SWOT Analysis
  • 11.3.9 Bersinbio Recent Developments
• 11.4 diagbio
  • 11.4.1 diagbio Corporation Information
  • 11.4.2 diagbio Business Overview
  • 11.4.3 diagbio DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.4.4 diagbio DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.4.5 diagbio DNA Methylation Modification Kit Sales by Product in 2024
  • 11.4.6 diagbio DNA Methylation Modification Kit Sales by Application in 2024
  • 11.4.7 diagbio DNA Methylation Modification Kit Sales by Geographic Area in 2024
  • 11.4.8 diagbio DNA Methylation Modification Kit SWOT Analysis
  • 11.4.9 diagbio Recent Developments
• 11.5 New England Biolabs
  • 11.5.1 New England Biolabs Corporation Information
  • 11.5.2 New England Biolabs Business Overview
  • 11.5.3 New England Biolabs DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.5.4 New England Biolabs DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.5.5 New England Biolabs DNA Methylation Modification Kit Sales by Product in 2024
  • 11.5.6 New England Biolabs DNA Methylation Modification Kit Sales by Application in 2024
  • 11.5.7 New England Biolabs DNA Methylation Modification Kit Sales by Geographic Area in 2024
  • 11.5.8 New England Biolabs DNA Methylation Modification Kit SWOT Analysis
  • 11.5.9 New England Biolabs Recent Developments
• 11.6 Thermo Fisher Scientific
  • 11.6.1 Thermo Fisher Scientific Corporation Information
  • 11.6.2 Thermo Fisher Scientific Business Overview
  • 11.6.3 Thermo Fisher Scientific DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.6.4 Thermo Fisher Scientific DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.6.5 Thermo Fisher Scientific Recent Developments
• 11.7 Proteintech Group, Inc
  • 11.7.1 Proteintech Group, Inc Corporation Information
  • 11.7.2 Proteintech Group, Inc Business Overview
  • 11.7.3 Proteintech Group, Inc DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.7.4 Proteintech Group, Inc DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.7.5 Proteintech Group, Inc Recent Developments
• 11.8 Active Motif
  • 11.8.1 Active Motif Corporation Information
  • 11.8.2 Active Motif Business Overview
  • 11.8.3 Active Motif DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.8.4 Active Motif DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.8.5 Active Motif Recent Developments
• 11.9 Vazyme
  • 11.9.1 Vazyme Corporation Information
  • 11.9.2 Vazyme Business Overview
  • 11.9.3 Vazyme DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.9.4 Vazyme DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.9.5 Vazyme Recent Developments
• 11.10 A&A Biotechnology
  • 11.10.1 A&A Biotechnology Corporation Information
  • 11.10.2 A&A Biotechnology Business Overview
  • 11.10.3 A&A Biotechnology DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.10.4 A&A Biotechnology DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.10.5 A&A Biotechnology Recent Developments
• 11.11 QIAGEN
  • 11.11.1 QIAGEN Corporation Information
  • 11.11.2 QIAGEN Business Overview
  • 11.11.3 QIAGEN DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.11.4 QIAGEN DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.11.5 QIAGEN Recent Developments
• 11.12 Creative Biogene
  • 11.12.1 Creative Biogene Corporation Information
  • 11.12.2 Creative Biogene Business Overview
  • 11.12.3 Creative Biogene DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.12.4 Creative Biogene DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.12.5 Creative Biogene Recent Developments
• 11.13 EpiGenie
  • 11.13.1 EpiGenie Corporation Information
  • 11.13.2 EpiGenie Business Overview
  • 11.13.3 EpiGenie DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.13.4 EpiGenie DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.13.5 EpiGenie Recent Developments
• 11.14 BioChain
  • 11.14.1 BioChain Corporation Information
  • 11.14.2 BioChain Business Overview
  • 11.14.3 BioChain DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.14.4 BioChain DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.14.5 BioChain Recent Developments
• 11.15 Biosense
  • 11.15.1 Biosense Corporation Information
  • 11.15.2 Biosense Business Overview
  • 11.15.3 Biosense DNA Methylation Modification Kit Product Models, Descriptions and Specifications
  • 11.15.4 Biosense DNA Methylation Modification Kit Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.15.5 Biosense Recent Developments

12 Value Chain and Supply-Chain Analysis

• 12.1 DNA Methylation Modification Kit Industry Chain
• 12.2 DNA Methylation Modification Kit Upstream Materials Analysis
  • 12.2.1 Raw Materials
  • 12.2.2 Key Suppliers Market Share & Risk Assessment
• 12.3 DNA Methylation Modification Kit Integrated Production Analysis
  • 12.3.1 Manufacturing Footprint Analysis
  • 12.3.2 Regional Production Market Share (2020-2031)
  • 12.3.3 Regulatory and Trade Policy Impact on Production
  • 12.3.4 Production Technology Overview
  • 12.3.5 Regional Cost Drivers
• 12.4 DNA Methylation Modification Kit Sales Channels and Distribution Networks
  • 12.4.1 Sales Channels
  • 12.4.2 Distributors

13 DNA Methylation Modification Kit Market Dynamics

• 13.1 Industry Trends and Evolution
• 13.2 Market Growth Drivers and Emerging Opportunities
• 13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global DNA Methylation Modification Kit Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details